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Abstract
Omega and trans-fatty acids play important roles in atherogenesis of vascular 
system. In this review, we discuss such roles in health; there are much differences 
in coronary heart disease (CHD) rates between the US and Japan. Fatty acids 
profiles in the plasma are related to risks of CHD. There have been few studies that 
compared plasma levels of fatty acids, including trans-fatty acids, in people in 
Japan and the US. Plasma levels of long-chain omega-3 fatty acids (docosahexae-
noic acid [DHA] and eicosapentaenoic acid [EPA]) were higher in Japanese men, 
and omega-6 fatty acids (e.g., arachidonic acid [AA]) were lower compared with 
American men. American people had higher plasma levels of the major industri-
ally produced trans-fatty acids (IP-TFAs; elaidic and inoelaidic acids), and levels 
of the potentially cardioprotective, primarily ruminant-derived trans-fatty acid, 
palmitoelaidic acid (POA) were higher in Japanese men. Plasma levels of saturated 
or monounsaturated fatty acids were also higher in American men. Only intakes of 
preference drinks have significant correlation with plasma levels of palmitoelaidic 
acid and linoelaidic acid. The higher levels of DHA and EPA, along with the lower 
levels of the IP-TFAs, are consistent with the markedly lower risk for coronary heart 
disease in Japan vs. the US.
Keywords: trans-fatty acids, omega fatty acids, lipid, DHA, EPA,  
arachidonic acid, palmitoelaidic acid, elaidic acid, linoelaidic acid, food, protein, 
carbohydrate, preference drink, coffee, tea, cholesterol, GRP120, insulin, GLP-1
1. Introduction
Coronary heart disease (CHD) is the leading cause of death worldwide, 
and certain dietary fatty acids (FAs) are known to play an important role in 
CHD risk [1]. It has been reported that higher intakes of industrially produced 
trans-fatty acids (IP-TFA) [2] and of saturated fatty acids (SFAs) are associ-
ated with increased risk for CHD [3, 4] and that higher intakes of both the 
omega-6 (n-6) polyunsaturated fatty acids (PUFAs) and the omega-3 PUFAs 
are  associated with lower risk of CHD [5, 6]. Intakes of the PUFAs (especially 
the omega-3 class) and IP-TFAs are considered to be biomarkers strongly 
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linked to risks. Because risk for CHD is much lower in Japan than in the US [7], 
we tried to compare the FA profiles in Japanese and American men over the 
age of 50.
1.1 Configurations of trans-fatty acids and their origins
Trans-fatty acids have at least one double bond in the trans configuration and 
formed during partial hydrogenation of vegetable oils. This process is used for the 
conversion of vegetable oils to semisolid fats used for margarines.
Most of trans-fatty acids isomers are monosaturated with carbon number 18 
(trans type octadecenoic acid (t-C18:1)). Trans type octadecenoic acids contained 
in foods are classified 13 isomers depending upon the location of the double bond 
(Figure 1). These trans isomers are produced industrially or naturally. The largest 
amounts of industrially produced trans-fatty acids are elaidic acids (t 9-C18:1) and 
those of naturally produced forms are vaccenic acid (t11-C18:1) [8].
In the cis forms of fatty acids, hydrogen atoms are present on the same side of 
the bond, which causes a bend in the fatty acid chain, whereas the trans form has 
hydrogen atoms in the opposite sides of the chain, which straightens the fatty acid 
chain (upper figure). There are many isomers in carbon 18 fatty acids. Elaidic acid 
has the double bond at the ninth carbon atom (t9-18:1). Oleic acid has the double 
bond at the same location (c9-18:1). Partially hydrogenated oils contain mixture 
of isomers in which the trans form may be detected anywhere between the 4th 
and 14th carbon. Smaller amounts of isomers with a second trans double bond 
(trans,trans-18:2) are also present.
Figure 1. 
The configuration of cis and trans forms of the double bond.
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1.2 Molecular mechanisms of trans-fatty acids
Fatty acids modulate cell functions. They change membrane fluidity and 
responses of membrane receptors. Fatty acids not only bind to membrane receptors 
but also bind to and modulate nuclear receptors that regulate gene transcription, 
peroxisome-proliferator-activated receptors, liver X receptor, and sterol regula-
tory element-binding protein 1 [9] (Figure 2). Fatty acids modulate metabolic and 
inflammatory responses of the endoplasmic reticulum [10].
Trans-fatty acids change the secretion, lipid composition, and the size of 
apoB100 produced by hepatic cells [11, 12]. In hepatocytes, trans-fatty acids 
increase the accumulation and secretion of free cholesterol and cholesterol esters 
[11]. Trans-fatty acids increase plasma activity of cholesteryl ester transfer protein 
[13], which may result in decreases in plasma levels of high density lipoprotein 
(HDL) and increase in the levels of low density lipoprotein (LDL) and very low 
density lipoprotein (VLDL).
Trans-fatty acids modulate monocyte and macrophage functions resulting in 
increase in the production of tissue necrosis factor (TNF)-α and interleukin-6 [14]. 
Endothelial dysfunctions are caused by trans-fatty acids, and arterial dilatation is 
impaired due to nitric oxide [15].
Fatty acid metabolism of adipocytes was affected by trans-fatty acids, causing 
reduced triglyceride uptake, reduced esterification of cholesterol, and increased pro-
duction of free fatty acids [16]. In animal studies, the gene expression was changed 
by the consumption of trans-fatty acids in adipocytes. These gene products are 
peroxisome-proliferator-activated receptor-γ, resistin, and lipoprotein lipase [17].
Trans-fatty acids may affect plasma lipid levels due to changes in hepatocytes 
of the production, secretion, and catabolism of lipoproteins and plasma levels of 
Figure 2. 
Effects of trans-fatty acids.
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cholesteryl ester transfer protein (CETP) (upper left panel). In adipocytes, trans-
fatty acids change fatty acid metabolism and, possibly, inflammatory responses. 
When trans fats are taken, nitric acid-dependent endothelial dysfunction is 
observed and circulating adhesion molecules increase. Trans fat modulates mono-
cyte and macrophage function (lower left panel). Membrane receptors may affect 
subcellular mechanisms. These receptors localize with and are influenced by spe-
cific membrane phospholipids (upper right panel) such as endothelia nitric oxide 
synthetase or toll-like receptors. Trans-fatty acids may bind to nuclear receptors-
regulating gene transcription such as liver X receptor (lower left panel).
1.3 Effects on cardiovascular diseases
Trans-fatty acids may increase the risks of coronary heart disease (CHD). In a 
meta-analysis of four prospective cohort studies, a 2% increase in energy intake 
from trans-fatty acids was shown to be associated with a 23% increase in the 
incidence of CHD [18–21].
There are many papers showing increased risks of CHD in patients with 
high fatty acids levels [22–25]. These data are obtained using cohorts of Western 
populations.
Koba et al. [26] recently reported using Japanese adult males that total trans-
fatty acids levels were similar between acute coronary syndrome (ACS) and control 
subjects. Palmitelaidic acid levels were lower in ACS patients and were significantly 
directly associated with HDL cholesterol (HDL-C) and n-3 polyunsaturated FA 
(n-3 PUFA). Linoleic trans isomers (total C18:2 TFA) and primary industrially pro-
duced TFA (IP-TFAs) were significantly higher in ACS patients. Total trans-C18:1 
isomers were comparable between ACS and control.
1.4 Intakes of trans-fatty acids in people of US and Japan
Allison et al. [27] used food intake data from1989 to 1991 Continuing Survey of 
Food Intakes by Individuals (CSFII) and the trans-fatty acid contents of specific 
foods, which were calculated from a data base of the US Department of Agriculture. 
These data show the mean levels of trans-fatty acids intakes of US population.
The average percentage of energy ingested as trans-fatty acids was 2.6%, and 
the average percentage of total fat ingested as trans-fatty acids was 7.4%. Across all 
age and gender groups examined, estimates ranged from 2.6 to 2.8% and 7.1 to 7.9%, 
respectively [27].
In Japan, mean total fat and trans-fatty acid intake was 56.9 g/day (27.7% total 
energy) and 1.7 g/day (0.8% total energy), respectively, for women and 66.8 g/day 
(25.5% total energy) and 1.7 g/day (0.7% total energy) for men [28].
Recent studies indicate that the average trans-fatty acids intake was estimated to 
be 0.92–0.96 g/day, which was 0.44–0.47% of total daily energy intakes [29].
These data indicate that Japanese take far less amounts of trans-fatty acids 
compared with American.
1.5 Omega fatty acids
Intakes of long-chain ω-3 fatty acids (eicosapentaenoic acid (EPA), docosa 
pentaenoic acid (DPA), and docosahexanoic acid (DHA)) found in fish, and fish 
oils has been shown to be related to the low incidence of coronary heart disease in 
the Inuit people of Greenland [30].
We do not review roles of such fatty acids in health and disease in details.
Figure 3 summarizes roles of EPA in causing various dysfunctions of the body.
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Arachidonic acid (n-6 polyunsaturated fatty acid “PUFA”) is converted to PGH2 
(prostaglandin H2, which is converted to prostaglandin E2, inflammatory mediator) 
or to TXA2 (thromboxane A2), causing thrombosis. AA is also converted to LTA4 
(leukotriene A2), then to leukotriene B4, inflammatory mediator [31].
Cells produce TNF-α or interleukin (IL)-1β, which case cell damages.
Figure 3. 
Roles of EPA in the prevention of cell damage, inflammation, or thrombosis.
Figure 4. 
Function of G-protein-coupled receptor 120 as a receptor of DHA and EPA.
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EPA inhibits such processes, preventing cell damages, inflammation, and 
thrombosis. DHA may work in the similar ways as EPA.
1.6 ω fatty acid receptor
GPR120 is proposed to function as an ω-3 FA receptor/sensor in pro-inflamma-
tory macrophages and mature adipocytes. By signaling through GPR120, DHA and 
EPA mediate potent anti-inflammatory effects to inhibit both TLR (toll-like recep-
tor) and TNF-α inflammatory signaling pathways [32].
DHA and EPA stimulate GRP 120 and cause a decrease of glucose uptake by 
adipocytes, inhibit inflammation by macrophages, secrete glucagon-like peptide 1 
(GLP-1), and increase insulin secretion by pancreas (Figure 4).
These data suggest that DHA and EPA may be effective for prevention and treat-
ment of cardiovascular disease and diabetes mellitus.
2.  Differences of plasma levels of fatty acids between Japanese and 
American old men
2.1 Materials and methods
2.1.1 Participants
In Japan, we recruited 44 male volunteers older than 50. They were friends and 
family members of the research team for this study [33, 34]. Exclusion criteria 
included the use of medications to treat diabetes, hyperlipidemia, hypertension, 
and/or cardiovascular disease (CVD). Smokers were also excluded. The 76 US men 
were participants in the Chicago Area Sleep Study, a prospective cohort study to 
examine risk factors for the development of sleep disorders [35]. This cohort excluded 
men with known sleep disturbances but did not exclude for the chronic conditions 
excluded in the Japanese cohort. We collected blood samples after an overnight fast, 
and plasma was isolated for fatty acid analysis. We obtained an informed consent 
prior to conducting the protocol which had been approved by the Ethical Committee 
of Showa Women’s University and Saiseikai Shibuya Satellite Clinic. The Chicago Area 
Sleep Study was approved by the Northwestern University Institutional Review Board.
2.2 Analyses of plasma samples
Fatty acids levels were measured in plasma obtained from ethylenediamine 
tetraacetic acid anticoagulated blood samples. Samples were frozen at −80°C until 
analyzed at Omegaquant, LLC (Sioux Falls, SD, USA). After thawing, an aliquot of 
plasma was combined (1.40 parts) with the methylating mixture (boron trifluoride 
in methanol [14%], toluene, and methanol [35/30/35, vv]), shaken at 100°C for 
45 min. After cooling, 40 parts of both hexane and distilled water were added. 
After briefly vortexing, the samples were spun to separate layers, and an aliquot 
of the hexane layer that contained the fatty acid methyl esters was analyzed by gas 
chromatography as previously described.
2.3 Statistical analysis
Student’s t test was used for the comparison of two groups, and p < 0.05 was 
considered as significant difference. Results are expressed as mean ± SD. Spearman’s 
correlation tests were used to examine statistical significance.
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3. Results
The ages of the two cohorts was reasonably similar (Japan, 61 ± 10 and US, 
57 ± 5 years), as were the body mass indexes (24.9 ± 3.7 vs. 25.1 ± 3.4 kg/m2) (Figure 5).
Of the fatty acids that constituted at least 1% of the total in either cohorts, those that 
are significantly higher in Japanese men than US men were as follows: palmitic, palmi-
toleic, arachidic, EPA, and DHA. Those that were lower in the Japanese men were as 
follows: linoleic acid (LA), dihomo-gamma linolenic acid (DGLA), and AA (Table 1).
Figure 5. 
Profiles of plasma levels of fatty acids of Japanese and American old men.
Japanese (n = 44) American (n = 76)
Age 62.4 ± 9.6 57.5 ± 4.3
Height (m) 1.68 ± 0.07 1.70 ± 0.1
Weight (kg) 68.8 ± 10.9 74.4 ± 12.1
Body mass index (BMI) 24.3 ± 3.2 25.3 ± 3.4
Total cholesterol (mg/dL) 209.9 ± 32.3 185 ± 33.5
Triglyceride (mg/dL) 126.4 ± 81.3 118.0 ± 62.8
HDL-C (mg/dL) 60.9 ± 16.6 54.0 ± 15.7
LDL-C (mg/dL) 123.8 ± 30.2 107.0 ± 29.6
Fasting blood glucose (mg/dL) 91.7 ± 16.3 97 ± 22.3
Table 1. 
Backgrounds of various parameters of healthy old men in Japan and US.
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Figure 6 compares plasma levels of palmitoelaidic, elaidic, and linoelaidic acids.
IP-TFAs (elaidic and mainly industrially produced linoelaidic), 
although of low abundance in both cohorts, were considerably higher in the 
US than in Japan. Palmitoleic was slightly but significantly higher in Japan 
(Figure 7).
Plasma levels of DHA and EPA are higher in Japanese than American old men; 
on the other hand, plasma levels of arachidonic acid and dihomoγlinoleinic acid are 
higher in American than Japanese old men.
Figure 7. 
Comparison of plasma levels of C20–22 fatty acids between Japanese and American old men.
Figure 6. 
Plasma levels of trans-fatty acids in Japanese and American old men.
9Roles of Trans and ω Fatty Acids in Health; Special References to Their Differences…
DOI: http://dx.doi.org/10.5772/intechopen.89551
Table 2 summarizes plasma levels of important fatty acids between Japanese and 
American men.
4. Food intakes and plasma levels of fatty acids
Participants were given self-administered diet history questionnaires and 
described answers on each item by recollection of diets they took (7 days dietary 
recall). We used a brief-type self-administered diet history questionnaire 
(BDHQ ) by using which the Japanese Ministry of Health, Labour and Welfare 
reports National Nutrition Surveys. From these questionnaires, we calculated the 
intakes of energy and varieties of foods such as proteins, carbohydrates, lipids 
vitamins, etc.
4.1 Results
Table 3 shows that only preference drinks such as tea and coffee had significant 
correlations with plasma levels of palmitoelaidic acid and linoelaidic acid.
Plasma fatty acids (% of total) Japanese (n = 44) US (n = 76) ss
Myristic 0.7 ± 0.2 0.85 ± 0.34 **
Palmitic 22.3 ± 1.3 21.23 ± 2.13 *
Palmitoelaidic (trans) 0.2 ± 0.1 0.14 ± 0.07 **
Palmitoleic 1.9 ± 0.6 1.45 ± 0.80 **
Stearic 7.0 ± 0.7 7.24 ± 0.83
Elaidic (trans) 0.1 ± 0.01 0.61 ± 0.34 **
Oleic 20.0 ± 2.6 19.96 ± 3.34
Linoelaidic (trans) 0.2 ± 0.1 0.35 ± 0.12 **
Linoleic (LA) 26.3 ± 4.0 32.83 ± 5.24 **
Arachidic 0.13 ± 0.04 0.13 ± 0.04
Gamma linolenic 0.3 ± 0.1 0.53 ± 0.27 **
Eicosenoic 0.2 ± 0.04 0.15 ± 0.05
Alpha-linolenic 0.7 ± 0.2 0.72 ± 0.32
Eicosadienoic 0.2 ± 0.03 0.29 ± 0.07 **
Behenic 0.15 ± 0.02 0.20 ± 0.10 **
Dihomo-gamma linolenic (DGLA) 1.0 ± 0.2 1.56 ± 0.37 **
Arachidonic (AA) 6.0 ± 1.1 7.38 ± 2.18 **
Eicosapentaenoic (EPA) 2.5 ± 1.3 0.77 ± 0.60 **
Lignoceric 0.22 ± 0.10 0.18 ± 0.07 *
Nervonic 0.33 ± 0.18 0.26 ± 0.10 *
Docosatetraenoic 0.12 ± 0.04 0.26 ± 0.11 **
Docosapentaenoic (n6) 0.14 ± 0.04 0.18 ± 0.08 **
Docosapentaenoic (n3) 0.68 ± 0.26 0.59 ± 0.14 *
Docosahexaenoic (DHA) 5.0 ± 1.5 2.14 ± 0.85 **




Comparison of fatty acids profiles between Japanese and American men.
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Palmitelaidic Elaidic Linoelaidic
Energy 0.319 −0.135 0.181
Protein 0.239 0.031 0.034
Animal protein 0.233 0.135 0.034
Vegetable protein 0.193 −0.081 0.152
Lipid 0.187 0.120 0.034
Animal lipid 0.188 0.154 0.094
Vegetable lipid 0.167 0.027 −0.066
Carbohydrate 0.188 −0.197 0.138
Na 0.128 0.033 −0.073
K 0.223 −0.015 0.137
Ca 0.099 0.263 −0.021
Mg 0.283 −0.003 0.143
Phosphorus 0.230 0.088 0.020
Iron 0.193 −0.120 0.112
Zinc 0.109 0.081 0.072
Copper 0.211 −0.066 0.163
Mn 0.422 −0.059 0.113
Retinol 0.307 −0.195 0.054
β-Carotene −0.001 −0.049 −0.005
Vit D 0.295 −0.001 −0.066
Tocopherol 0.167 −0.049 −0.004
Vit K 0.098 0.014 0.083
Vit B1 0.095 0.119 0.098
Vit B2 0.246 0.169 0.135
Niacine 0.320 −0.012 0.081
Vit B6 0.239 −0.036 0.129
Vit B12 0.353 −0.090 0.049
Folic acid 0.333 −0.120 0.080
Pantothenic acid 0.299 0.120 0.083
Vit C 0.214 −0.040 0.034
Saturated fatty acids 0.209 0.144 0.112
Monovalent fatty acids 0.156 0.126 −0.004
Multivalent fatty acids 0.179 0.024 −0.062
Cholesterol 0.221 −0.025 0.125
Soluble dietary fiber 0.133 −0.080 0.155
Insoluble dietary fiber 0.125 −0.047 0.076
Total dietary fiber 0.082 0.027 0.089
Salt 0.128 0.033 −0.073





Correlations between foods intake and plasma levels of fatty acids.
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5. Discussion
Fatty acids are major components of blood vessels. So their changes exert 
tremendous impact to pathophysiology of cardiovascular system.
Epidemiological studies repeatedly showed that Japanese people had lower 
incidence of CVD, compared with American people [7]. As discussed below, kinds 
of intaken foods, life-styles, and genetics may contribute to such differences.
We thought the measurements of fatty acids composition in plasma may help to 
elucidate such differences between Japanese and American people.
We compared plasma levels of fatty acids between Japanese and American men 
over 50 years of age. We found, not surprisingly, that levels of EPA and DHA are 
higher in Japanese than American and that levels of arachidonic acid are lower 
in Japanese. Although both Japanese and American take meat, egg, and fish, fish 
has far more omega-3 fatty acids compared to eggs. When we eat larger amounts 
of omega-3 fatty acids such as DHA and EPA, omega-3 fatty acids are known to 
replace omega-6 fatty acids in cell membrane [36]. The omega-3 fatty acids are 
found predominantly in oily fish, whereas arachidonic acid (the major long chain 
omega-6 fatty acid) is contained in meats and eggs and can be synthesized (albeit 
very slowly) [37]. The differences between Japanese and US men in regard to the 
consumption of these types of foods can help explain these differences in blood 
levels [38]. The other major finding of this study was the lower levels of IP-TFA such 
as linoelaidic acid in Japanese vs. the US men.
Currently, CHD death rates in Japan are 3× lower for women and 4× lower 
for men (ages 35–74) compared with the US. Among 30 countries for which the 
American Heart Association provided CHD death rates in its 2017 Statistical 
Update [7], Japan had the second and third lowest rates (men and women, 
respectively) compared with the US. Sekikawa et al. [39] showed in 2014 that 
the calcification of the coronary artery was twice in American compared with 
Japanese men, but the calcification of Hawaiian Japanese was similar to that of 
people on the US mainland.
These results do not necessarily prove differences of CVD incidences between 
Japanese and American are due to foods and lifestyle. Since Japanese immigrants 
to the US have increased CHD mortality [40], although still lower US Whites, it 
appears that some genetic variabilities between American and Japanese must be 
responsible for this difference. However, the possibility that differences in dietary 
fatty acid patterns may contribute to this phenomenon is the subject of this report.
We found that the levels of the long-chain omega-3 fatty acids such as EPA and 
DHA were 2–3× higher in Japan vs. the US. The relationship of fish and dietary 
omega-3 fatty acids and cardiovascular disease (CVD) has been investigated in 
numerous studies and comprehensive reviews and recommendations exist. Still 
controversies exist. A recent meta-analysis of randomized trials with omega-3 fatty 
acids [41] did not find a statistically significant reduction in CVD mortality, but in 
these researches, some important factors were said to be ignored [42–44]. Other 
systematic reviews have reported mortality benefits for omega-3 fatty acids [45, 
46], and omega-3 biomarker levels have been strongly associated with risk for fatal 
CHD in still other meta-analyses [47, 48]. Hence, higher omega-3 levels could at 
least partly explain the lower CHD risk in Japan.
We also found that IP-trans-fatty acid such as linoelaidic acid was lower in Japan 
than US. The reported intake of IP-TFA is 75% lower in Japan than in the US, again 
supporting the observed differences in biomarker levels. Circulating 18:2 trans-fatty 
acids was shown to be most adversely associated with total mortality, mainly due to 
the increased risk of CVD [23]. It was also positively associated with total mortality 
and CHD.
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It may be surprising that TFA is not necessarily adverse for health. Some are 
beneficial for health. In a recent study from Germany, total trans-fatty acids in 
erythrocyte membranes were shown to be inversely associated with mortality, but 
this was mainly driven by the naturally occurring 16:1 trans (trans-palmitoleic acid) 
[49]. As to relationship between IP-TFA or SFA intakes and CHD mortality, exces-
sive intakes of both had a greater impact on risk for CHD in the US compared with 
Japan, whereas insufficient intakes of omega-6 PUFAs had about the same impact 
on risk in both countries [50].
Our results also indicate that plasma levels of SFAs are higher in American 
than in Japanese. Saturated fatty acids are considered to be one of the dietary 
risk factors of CVD, primarily because these fats raise LDL-cholesterol levels. 
Many health and government organizations have recommended the reduction 
of intakes of SFA s to lower the incidence of CVD. Although this difference in 
SFA plasma levels may also be one of the reasons that Americans have a higher 
mortality rate for CVD than Japanese, plasma saturated (and monounsaturated) 
fatty acids are claimed to be relatively poor markers of dietary SFA (saturated 
fatty acid) intake [51].
Plasma fatty acid profiles in older men from Japan and US differed in many 
ways that are consistent with the lower rate of CHD in the former country. Efforts 
to lower TFA levels and increase EPA + DHA levels may help lower risk for CHD 
in the US, and current trends in Japan toward a more western diet [52] should be 
discouraged.
As to relationship between TFA or SFA intakes and CHD mortality, excessive 
intakes of both had a greater impact on risk for CHD in the US compared with 
Japan, whereas insufficient intakes of omega-6 PUFAs had about the same impact 
on risk in both countries [50]. As stated above, naturally occurring trans fats are 
consumed in smaller amounts (about 0.5% of total energy intake) in meats and 
dairy products from cows, sheep, and other ruminants; these trans fats are pro-
duced by the action of bacteria in the ruminant stomach [22]. Since trans-fatty 
acids are not used in foods in Japan, all the trans-fatty acids must come from meat 
or dairy products. We found that there was no relationship between various foods 
intake and plasma levels of trans-fatty acids in Japanese old men. Only intakes of 
preference drinks such as tea and coffee had significant relationship with plasma 
levels of palmitoelaidic acid and linoelaidic acid. These results seem to indicate that 
plasma levels of trans-fatty acids are not derived from foods but derived by intesti-
nal microbes.
Human gut microbes are important in neural, endocrine, and immune com-
munication with the host [53]. Communication is considered to be bidirectional. 
Mediators of microbiota-gut-brain communication affected by microbial 
metabolism include short-chain fatty acids, neurotransmitters such as serotonin, 
γ-aminobutyric acid (GABA), hormones such as cortisol, and immune system 
mediators such as quinolinic acid [51].
In conclusion, some of trans-fatty acids may be produced by hydrogenation of 
fatty acids by gut microbes.
6. Conclusion
We here report our results of comparison of plasma levels of fatty acids between 
healthy old men in Japan and the US.
The higher levels of DHA and EPA, along with the lower levels of the IP-TFAs, 
are consistent with the markedly lower risk for coronary heart disease in Japan vs. 
the US.
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